Loading company…
Regenesance develops drugs for acute and chronic nerve disorders.
Regenesance develops drugs focused on acute and chronic nerve disorders. Founded in 2009, the company is based in Amsterdam, Netherlands, and its listed stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in